VETERINARY TEAM REFERENCE

DEA & state schedules

Scheduling applies to the medication, not to the patient. This independent reference is not affiliated with the DEA.

Prazosin

FEDERAL STATUS

Not federally scheduled

The identified ingredients in this entry are not listed in the reviewed federal schedules. Prescription-only status, product restrictions and state law are separate questions.

Federal source ↗

State / prescribing or dispensing jurisdiction

STATE STATUS

Select a jurisdiction

Choose the state relevant to prescribing or dispensing. Patient residence alone may not determine every applicable rule.

What each federal schedule means

Highlighted rows match the verified federal or selected state schedule. The schedule describes legal control and abuse potential; it does not rank clinical usefulness or establish a dose.

Federal Schedules I–V: meaning and practice implications
Schedule	Meaning and practice
I	High abuse potential; no currently accepted medical use in U.S. treatment; lacks accepted safety under medical supervision. In practice: Not available for routine veterinary prescribing. Authorized research is a separate pathway.
II	High abuse potential; accepted medical use, sometimes with severe restrictions; abuse can cause severe dependence. In practice: No prescription refills under federal law. Strict prescribing, security and record requirements apply.
III	Less abuse potential than I or II; accepted medical use; abuse can cause moderate or low physical dependence or high psychological dependence. In practice: Federal prescriptions allow up to five authorized refills within six months. State rules may be stricter.
IV	Lower abuse potential than III; accepted medical use; limited dependence risk relative to III. In practice: The same federal five-refill / six-month prescription limit applies. Controlled-drug handling still applies.
V	Lower abuse potential than IV; accepted medical use; limited dependence risk relative to IV. In practice: Still controlled. Check authorized refills and state limits; do not automatically apply the III–IV refill rule.

What this means for the chart

For a controlled medication, confirm the prescriber’s authority for the applicable schedule, the exact formulation and quantity, authorized refills, secure handling, and required inventory / dispensing records. Check the state’s veterinary rules and any prescription monitoring program (PDMP) requirements or exemptions.

A PDMP reporting requirement does not by itself make a drug scheduled. “Not federally scheduled” does not mean over the counter, risk-free, or exempt from state law. States may use additional categories, such as Schedule VI, outside the federal I–V system.

← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Prazosin

An alpha-adrenergic blocker that relaxes vascular smooth muscle. Minipress is a human antihypertensive brand; any veterinary use of the human capsules is extra-label and must be tied to the veterinarian’s diagnosis and prescription.

Alpha-adrenergic blockerProduct-specific clinical reference

Updated October 16, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Minipress is a human antihypertensive; animal prescribing is extra-label.

Key prescribing checks

The human label warns about syncope and marked blood-pressure reduction, especially at treatment initiation. The veterinary prescriber should assess perfusion and concurrent blood-pressure-lowering drugs.
Review diuretics and other antihypertensive medicines because additive effects can occur.
A patient unable to pass urine needs urgent veterinary assessment; a medication identity match must not delay evaluation or relief of an obstruction.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs and cats

Extra-label

Veterinarian-selected alpha-blockade

Reviewed human label does not verify an animal indication or efficacy.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Blocks postsynaptic alpha-adrenoceptors and reduces vascular resistance.

Absorption, distribution, metabolism and elimination

Animal-specific pharmacokinetic parameters were not established by the reviewed label.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Minipress

Human prazosin capsules; veterinary use is extra-label.

Contraindications · when not to use

Sensitivity to prazosin, other quinazolines or capsule ingredients.

Precautions & monitoring

Syncope and marked hypotension can occur, especially when beginning treatment or changing therapy.

Safety sources checked: October 16, 2026. Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Human labeling warns of first-dose syncope, hypotension and dizziness; animal frequency is not established.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

A veterinary dose was not verified; human initiation/titration instructions are not an animal regimen.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Minipress

Human prazosin capsules; veterinary use is extra-label.

Other antihypertensives, diuretics, beta-blockers and PDE-5 inhibitors may add to blood-pressure lowering.

Interaction source ↗

Monitoring

Assess blood pressure and additive effects of other antihypertensives.

Client counseling

Report weakness or collapse promptly; inability to urinate remains an emergency requiring assessment.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Keep securely; follow the actual capsule label.

Brands, formulations & ingredient identity

Active ingredients

Prazosin

Other searchable names: Prazosin hydrochloride

Minipress identifies prazosin hydrochloride. The generic name may appear with or without the hydrochloride salt in a chart.

A drug name alone does not establish the cause of urinary signs or justify administration. This lookup identifies the ingredient, not a treatment pathway for straining or an obstructed patient.

Confirm capsule strength and the exact dispensing product. Human directions, capsule counts and blood-pressure targets do not supply a veterinary regimen.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Minipress

Formulation: Oral capsules
Label / product scope: Human product

Human-labeled prazosin product; species-specific veterinary prescribing is required.

Product label / source ↗

References & review status

Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

01DailyMed: Minipress prescribing information ↗02Official prescribing information ↗

Search another medication or supplement →

Prescribing overview

Key prescribing checks

Uses by species

Dogs and cats

Pharmacology & pharmacokinetics

Mechanism and clinical role

Absorption, distribution, metabolism and elimination

Contraindications & cautions

Contraindications · when not to use

Precautions & monitoring

Adverse effects

Dosing & administration

Drug & supplement interactions

Minipress

Monitoring

Client counseling

Storage & handling

Brands, formulations & ingredient identity

Active ingredients

Minipress

References & review status

Related Resources